000 | 01998 a2200505 4500 | ||
---|---|---|---|
005 | 20250516090452.0 | ||
264 | 0 | _c20120913 | |
008 | 201209s 0 0 eng d | ||
022 | _a1530-0307 | ||
024 | 7 |
_a10.1038/labinvest.2012.75 _2doi |
|
040 |
_aNLM _beng _cNLM |
||
100 | 1 | _aSpruss, Astrid | |
245 | 0 | 0 |
_aMetformin protects against the development of fructose-induced steatosis in mice: role of the intestinal barrier function. _h[electronic resource] |
260 |
_bLaboratory investigation; a journal of technical methods and pathology _cJul 2012 |
||
300 |
_a1020-32 p. _bdigital |
||
500 | _aPublication Type: Journal Article; Research Support, Non-U.S. Gov't | ||
650 | 0 | 4 | _aAnimals |
650 | 0 | 4 | _aDisease Models, Animal |
650 | 0 | 4 |
_aEndotoxins _xpharmacokinetics |
650 | 0 | 4 |
_aFatty Liver _xgenetics |
650 | 0 | 4 |
_aFructose _xadministration & dosage |
650 | 0 | 4 |
_aGene Expression _xdrug effects |
650 | 0 | 4 |
_aHypoglycemic Agents _xpharmacology |
650 | 0 | 4 | _aInsulin Resistance |
650 | 0 | 4 |
_aLiver _xdrug effects |
650 | 0 | 4 |
_aMatrix Metalloproteinase 13 _xgenetics |
650 | 0 | 4 |
_aMatrix Metalloproteinase 9 _xgenetics |
650 | 0 | 4 |
_aMetformin _xpharmacology |
650 | 0 | 4 | _aMice |
650 | 0 | 4 | _aMice, Inbred C57BL |
650 | 0 | 4 | _aNon-alcoholic Fatty Liver Disease |
650 | 0 | 4 |
_aPlasminogen Activator Inhibitor 1 _xgenetics |
650 | 0 | 4 |
_aRNA, Messenger _xgenetics |
650 | 0 | 4 |
_aSignal Transduction _xdrug effects |
650 | 0 | 4 |
_aTissue Inhibitor of Metalloproteinase-1 _xmetabolism |
650 | 0 | 4 |
_aToll-Like Receptor 4 _xgenetics |
650 | 0 | 4 |
_aTriglycerides _xmetabolism |
650 | 0 | 4 |
_aTumor Necrosis Factor-alpha _xgenetics |
700 | 1 | _aKanuri, Giridhar | |
700 | 1 | _aStahl, Carolin | |
700 | 1 | _aBischoff, Stephan C | |
700 | 1 | _aBergheim, Ina | |
773 | 0 |
_tLaboratory investigation; a journal of technical methods and pathology _gvol. 92 _gno. 7 _gp. 1020-32 |
|
856 | 4 | 0 |
_uhttps://doi.org/10.1038/labinvest.2012.75 _zAvailable from publisher's website |
999 |
_c21723868 _d21723868 |